WINTON GROUP Ltd Raises Holdings in DENTSPLY SIRONA Inc. $XRAY

WINTON GROUP Ltd lifted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 332.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 85,828 shares of the medical instruments supplier’s stock after acquiring an additional 66,000 shares during the period. WINTON GROUP Ltd’s holdings in DENTSPLY SIRONA were worth $981,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Daiwa Securities Group Inc. grew its stake in shares of DENTSPLY SIRONA by 2.9% during the fourth quarter. Daiwa Securities Group Inc. now owns 26,814 shares of the medical instruments supplier’s stock worth $306,000 after acquiring an additional 767 shares during the last quarter. Arizona State Retirement System grew its stake in shares of DENTSPLY SIRONA by 1.4% during the third quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock worth $748,000 after acquiring an additional 807 shares during the last quarter. Empowered Funds LLC grew its stake in shares of DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after acquiring an additional 1,320 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth about $26,000. Finally, Brevan Howard Capital Management LP grew its stake in shares of DENTSPLY SIRONA by 9.9% during the second quarter. Brevan Howard Capital Management LP now owns 20,002 shares of the medical instruments supplier’s stock worth $318,000 after acquiring an additional 1,800 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $10.47 on Wednesday. The stock has a 50-day simple moving average of $11.07 and a two-hundred day simple moving average of $11.72. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.98 and a current ratio of 1.53. The firm has a market capitalization of $2.10 billion, a P/E ratio of -3.32, a PEG ratio of 1.22 and a beta of 0.89. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.40 and a fifty-two week high of $17.09.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.83% and a negative net margin of 17.06%.The company had revenue of $880.00 million during the quarter, compared to analysts’ expectations of $841.80 million. During the same quarter in the prior year, the company posted $0.43 EPS. The company’s revenue for the quarter was up .1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.42 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Barrington Research lifted their target price on DENTSPLY SIRONA from $14.00 to $17.00 and gave the stock an “outperform” rating in a report on Monday, March 2nd. Weiss Ratings downgraded DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Citigroup assumed coverage on DENTSPLY SIRONA in a report on Wednesday, April 15th. They set a “sell” rating and a $10.00 target price for the company. Robert W. Baird lifted their target price on DENTSPLY SIRONA from $12.00 to $14.00 and gave the stock a “neutral” rating in a report on Friday, February 27th. Finally, UBS Group decreased their target price on DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating for the company in a report on Thursday, May 7th. Three analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $13.55.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.